We previously reported that PD-1 and PD-1 ligand 1 (PD-L1) expression levels were associated with poor prognosis and correlated with transforming growth factor (TGF)-β and forkhead box P3 (Foxp3) expression in CRC patients [5]. This evidence concerns the gene FOXP3 and colorectal carcinoma.